Technology-Based Intervention for Reducing Sexually Transmitted Infections and Substance Use During Pregnancy

Sponsor
University of Michigan (Other)
Overall Status
Recruiting
CT.gov ID
NCT03826342
Collaborator
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (NIH)
250
1
2
57.6
4.3

Study Details

Study Description

Brief Summary

This proposed study is to test whether Health Check-up for Expectant Moms (HCEM), a computer-delivered screening and brief intervention (SBI) that simultaneously targets sexually transmitted infection (STI) risk and alcohol/drug use during pregnancy, reduces antenatal and postpartum risk more than an attention, time, and information matched control condition among pregnant women seeking prenatal care.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Health Check-up for Expectant Moms
  • Behavioral: Time, attention, and information-matched control
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
250 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Technology-Based Intervention for Reducing Sexually Transmitted Infections and Substance Use During Pregnancy
Actual Study Start Date :
Apr 16, 2019
Anticipated Primary Completion Date :
Feb 1, 2024
Anticipated Study Completion Date :
Feb 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Health Check-up for Expectant Moms

Theory-driven and derived from empirical support

Behavioral: Health Check-up for Expectant Moms
A brief intervention (one session plus two booster sessions)

Active Comparator: Time, attention, and information-matched control

Well-validated

Behavioral: Time, attention, and information-matched control
We will include facts about alcohol/drug use and risky sex during pregnancy, along with informational brochures that provide face validity.

Outcome Measures

Primary Outcome Measures

  1. Number of unprotected sexual occasions (USOs) [Baseline]

    Timeline Follow-Back (TLFB) is used to assess USOs which are sex-risk behaviors . The TLFB is a calendar assisted structured interview that provides a way to cue memory so that accurate recall is enhanced for event-level data; it has been used to assess sexual risk-taking. USOs will be assessed in the 90 days prior to the baseline, as well as the 8-week follow-up assessments.

Secondary Outcome Measures

  1. Number of days of alcohol use measured by Timeline Follow-Back (TLFB) [8 week follow-up]

    Number of days of alcohol use will be measured by the TLFB by using the variable of percent days abstinent.

  2. Number of days of illicit drug use measured by Timeline Follow-Back (TLFB) [8 week follow-up]

    Illicit drug use will also be collected from the TLFB, and measured by using the "yes/no" variable for each day.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • At least one unprotected vaginal (or anal) sex occasion in the past 30 days

  • Having more than one male sex partner in the last 6 months and/or having uncertainty about current partner's monogamy.

  • Pregnant

  • Current or past patient of Michigan Medicine

  • Current alcohol/drug use risk.

Exclusion Criteria:
  • Unable to understand English

Contacts and Locations

Locations

Site City State Country Postal Code
1 West Ann Arbor Health Center Ann Arbor Michigan United States 48104

Sponsors and Collaborators

  • University of Michigan
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Investigators

  • Principal Investigator: Golfo Tzilos Wernette, University of Michigan

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Golfo Tzilos, Assistant Professor of Family Medicine and Assistant Professor of Psychiatry, University of Michigan
ClinicalTrials.gov Identifier:
NCT03826342
Other Study ID Numbers:
  • HUM00143896
  • 1R01HD093611-01A1
First Posted:
Feb 1, 2019
Last Update Posted:
Oct 11, 2021
Last Verified:
Oct 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 11, 2021